@article{oai:shiga-med.repo.nii.ac.jp:00003457,
 author = {辰巳, 剛一 and 河原, 真大 and 今井, 隆行 and 浅井, 愛 and 西田, 淳史 and 稲富, 理 and 木藤, 克之 and 安藤, 朗 and TATSUMI, Goichi and KAWAHARA, Masahiro and IMAI, Takayuki and NISHISHITA-ASAI, Ai and NISHIDA, Atsushi and INATOMI, Osamu and YOKOYAMA, Akihiko and KAKUTA, Yoichi and KITO, Katsuyuki and ANDOH, Akira},
 journal = {Leukemia},
 month = {Oct},
 note = {Thiopurines are widely used as antileukemia agents and immunosuppressants. Recent large-scale clinical studies revealed a strong association between the NUDT15 p.Arg139Cys (NUDT15R139C) polymorphism and severe thiopurine-induced leukocytopenia. We established knock-in mice harboring p.Arg138Cys (Nudt15R138C), which corresponds to the human polymorphism. A clinically relevant dose of mercaptopurine (MP) induced lethal cytopenia in Nudt15R138C-harboring mice. MP dose reduction attenuated the hematopoietic toxicity, phenocopying clinical observations and providing Nudt15 genotype-based tolerable doses of MP. High-dose MP induced acute damage to hematopoietic stem and progenitor cells (HSPCs) in Nudt15R138C/R138C mice. A competitive transplantation assay revealed that not only Nudt15R138C/R138C HSPCs, but also Nudt15+/R138C HSPCs suffered stronger damage than Nudt15+/+ HSPCs, even by lower-dose MP, after long-term administration. In a Nudt15 genotype-based posttransplantation leukemia recurrence model generated by bone marrow replacement with congenic wild-type cells and a small number of leukemia stem cells, MP prolonged the survival of mice with posttransplantation Nudt15R138C/R138C leukemia recurrence. In conclusion, our model will facilitate NUDT15 genotype-based precision medicine by providing safer estimates for MP dosing, and our findings highlighted the high susceptibility of hematopoietic stem cells to MP and suggested that exploiting thiopurine toxicity might be a novel treatment approach for leukemia in NUDT15R139C-harboring patients., Journal Article},
 title = {Thiopurine-mediated impairment of hematopoietic stem and leukemia cells in Nudt15R138C knock-in mice.},
 year = {2019}
}